نتائج البحث

Daily practice treatment and Influence of Visanne on the patient Assessment of quality of life parameters قائمة الدراسات السريرية المسجلة على الادوية

PARACETAMOL, DEXTROMETHORPHAN, PSEUDOEPHEDRINE قائمة المستحضرات المسجلة الغير متوفرة

A Phase IV Double-Blind Placebo-Controlled Randomized Clinical Trial Assessing the Effect of 2 month consumption of Vetal Laban Including Lactobacillus acidophilus NCFM on Functional Gastrointestinal Symptoms Among Subjects Fulfilling Rome III Criteria for A Phase IV, Randomized, double-blind, placebo-controlled study with parallel groups Irritable Bowel Syndrome قائمة الدراسات السريرية المسجلة على الادوية

Phase 2, Multi-Center, Double-Blind, Randomized, 2-Arm, Parallel Study to Assess the Efficacy and Safety of Ryanodex (EGL-4104) as Adjuvant Treatment in Subjects with Exertional Heat Stroke (EHS) قائمة الدراسات السريرية المسجلة على الادوية

A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Sitagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes قائمة الدراسات السريرية المسجلة على الادوية

Phase 2, Single-Site, Open-Label, Randomized, 2-ArmParallel Study to Assess the Efficacy and Safety ofRyanodex® (EGL-4104) as Adjuvant Treatment inSubjects With Exertional Heat Stroke (EHS قائمة الدراسات السريرية المسجلة على الادوية

سحب عدة تشغيلات من مستحضر (‎CHAMPIX 0.5 MG &1 MG F-C TABLETS) (CHAMPIX 1MG F-C TABLETS) من إنتاج شركة (R-PHARM GERMANY GMBH) السحب و الإستدعاءات

A PHASE 2A, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL PF-06651600 AND PF 06700841 AS INDUCTION AND OPEN LABEL EXTENSION TREATMENT IN SUBJECTS WITH MODERATE TO SEVERE CROHN’S DISEASE قائمة الدراسات السريرية المسجلة على الادوية

"A 2-treatment period, randomized, placebo-controlled,multicenter parallel-group study to assess the safety ofQAW039 when added to existing asthma therapy in GINAsteps 3, 4 and 5 patients with uncontrolled asthma" قائمة الدراسات السريرية المسجلة على الادوية

A Phase III, Multicentre, International, Randomised, Parallel Group, Double Blind Cardiovascular Safety Study of BI 10773 (10 mg and 25 mg Administered Orally Once Daily) Compared to Usual Care in Type 2 Diabetes Mellitus Patients With Increased Cardiovascular Risk قائمة الدراسات السريرية المسجلة على الادوية

عرض 41 - 50 من 2048